Christopher T. Sng

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome.

Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome.

Journal: Immunity

Published: August 12, 2025

Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.

Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.

Journal: Frontiers in immunology

Published: December 01, 2023

Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens.

Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens.

Journal: World journal of urology

Published: August 21, 2023

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.

Journal: Clinical genitourinary cancer

Published: November 23, 2022

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 11, 2022

Avelumab in locally advanced or metastatic urothelial carcinoma.

Avelumab in locally advanced or metastatic urothelial carcinoma.

Journal: Expert review of anticancer therapy

Published: January 11, 2022

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.

Journal: Cancers

Published: October 25, 2021

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 06, 2021

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Journal: Journal for immunotherapy of cancer

Published: February 05, 2021

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.

Journal: Frontiers in oncology

Published: August 17, 2020

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.

Journal: Cancers

Published: June 29, 2020

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Journal: Cancer discovery

Published: May 29, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026